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As a luminogram, coronary angiography provides a good
overview of the coronary artery tree. Using quantitative
coronary measurements, the degree of coronary obstruction
can be determined. The limitation of coronary angiography is
that it does not provide information on the arterial wall structure
and therefore cannot assess the extent of atherosclerosis.
Knowledge about adaptive coronary remodelling processes as
compensatory enlargement of the coronary artery has focused
diagnostic interest on the non-stenotic lesions of the coronary
tree. Intravascular ultrasound (IVUS) can reveal discrepancies
between the extent of coronary atherosclerosis and
angiography imaging by in vivo plaque imaging. Spectrum
analysis of IVUS-derived radiofrequency (RF) data enables a
more detailed analysis of plaque composition and morphology.
Preliminary in vitro studies correlated four histological plaque
components with a specific spectrum analysis of the RF data.
The different components (fibrous, fibrofatty, necrotic core and
dense calcium) are colour coded. Coronary tissue maps were
reconstructed from RF data using IVUS–Virtual Histology
(VH IVUS) software (Real-Time VH, Volcano Corporation,
Rancho Cordova, California, USA). VH IVUS has the potential
to detect high-risk lesions and can provide new insights into the
pathophysiology of coronary artery disease. VH IVUS allows
the differentiation of different lesion types based on information
derived from histopathology. The in vivo specific histological
analysis of coronary atherosclerosis may allow better
stratification of treatment of patients with coronary artery
disease.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Dr A Ko¨nig, Department of
Medicine, Division of
Cardiology, Medizinische
Poliklinik – Innenstadt,
Ludwig – Maximilians –
Universita¨t, Ziemssenstr 1,
80336 Munich, Germany;
andreas.koenig@
med.uni-muenchen.de
Accepted 9 February 2007
Published Online First
13 May 2007
. . . . . . . . . . . . . . . . . . . . . . . .
HISTORY AND DEVELOPMENT OF THE
TECHNOLOGY
Intravascular ultrasound (IVUS) has been used
since the 1990s as an additional tool for the
examination of coronary arteries. Its ability to
analyse vessel dimensions and pinpoint location of
coronary plaques has been used for guidance of
coronary interventions,1 analysis of ambiguous
lesions especially, left main coronary artery dis-
ease2 and clarification of the mechanism of in-
stent restenosis and transplant vasculopathy.3 4
Owing to its comprehensive insight into peri-
procedural vessel dimensions, discrepancies
between coronary angiography and IVUS imaging
when assessing the extent and severity of coronary
atherosclerosis were detected.5
IVUS is able to identify ruptured lesions, and
recent studies showed that IVUS parameters
indicated the risk for future plaque rupture.6 The
use of IVUS in progression–regression trials
provides the assessment of atheroma burden
under specific medical influences such as statin
therapy.7 IVUS imaging is limited for assessing the
exact analysis of the plaque composition. Both
calcified and dense fibrotic tissues have strong
echo reflections with lateral shadowing and are,
therefore, not easy to differentiate. The differential
diagnoses of areas with low echo reflections
include lipid-rich or fibrotic tissue, intraplaque
haemorrhage or even thrombus and lumen area.
Because of the limitations of the greyscale
analysis the importance of processing data from
ultrasound backscattered RF-signals to determine
the plaque composition was realised.
Spectral analysis of the RF signals provides a
more detailed assessment of the plaque. Early
studies with backscatter analysis showed a possi-
ble differentiation between different tissue types in
vitro.8
In recent studies, specific spectral parameters
have been found to be indicative for certain tissue
types after data aquisition with a 10 MHz trans-
ducer and spectrum analysis with fast Fourier
transformation.9 Studies using transducers with
higher frequencies10 11 showed that spectral analy-
sis is able to discriminate between different tissue
types.
Nair et al12 confirmed the superiority of auto-
regressive analysis over classic Fourier analysis in
the determination of plaque composition. Four
major plaque components of the coronary plaque
have been identified to date (fibrous, fibrofatty,
necrotic core and dense calcified tissue).
In this study, the ability of RF analysis to assess
the plaque vulnerability was investigated.
DESCRIPTION AND USE OF THE
TECHNIQUE
IVUS is an imaging technique enabling real-time
high-resolution tomographic viewing of the cor-
onary arteries. The morphology and distribution of
the coronary plaques can be analysed. In addition,
qualitative analysis and plaque characterisation is
possible based on differing echogeneicity. Echo
signals with poor reflection represent lipidic areas.
Echo signals with strong reflection and lateral
shadowing represent calcified areas.13
In traditional greyscale IVUS, the amplitude of
the echo signal is used for interpretation of data
difficult to analyse the different shades of grey
Abbreviations: ACS, acute coronary syndrome; RF,
radiofrequency; TCFA, thin cap fibroatheroma
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(fig 1). Tissue characterisation is not provided. In addition to
greyscale IVUS, the VH IVUS software (Volcano Corporation,
Rancho Cordova, California, USA) enables automated border
contour detection by estimation of the lumen and adventitial
borders by spectral analysis. After planimetry, tissue classifica-
tion is performed for the plaque area.
VH IVUS acquisition is performed during standardised IVUS
pullback (Eagle Eye Gold catheter, Volcano Corporation; 3.5F/
20 MHz) with use of VH IVUS console (Volcano Corporation).
RF data are obtained for on-line greyscale IVUS imaging and
VH IVUS imaging during the same pullback.
All IVUS catheters have variability in power output and
signal-receiving sensitivity. Therefore, prior efforts at standar-
disation for border automation and tissue characterisation on
greyscale IVUS were not successful. VH IVUS uses the raw RF
signal and an elaborate automatic calibration technology (blind
deconvolution) normalising for catheter-to-catheter and sys-
tem-to-system variability allowing standardised image inter-
pretation and tissue characterisation.
On the basis of ex vitro analysis, IVUS-derived RF analyses
were compared with corresponding histopathological areas. The
corresponding RF analyses were evaluated and the respective
spectrum curves with spectrum parameters were calculated.
Four major plaque components of the coronary plaque have
been identified to date (fibrous, fibrofatty, necrotic core and
dense calcified tissue; fig 2). The predictive accuracy for the
specific plaque components is approximately 93.4% for fibrous
and 94.6% for fibrofatty tissue, 95.1% for necrotic core and
96.8% for dense calcium.14
Fibrous tissue is identified as a dark green group of pixels on
the VH IVUS screen. This tissue is characterised by bundles of
collagen fibres with little or no lipid accumulation in the fibrous
area and no evidence of macrophages representing inflamma-
tory response. Fibrofatty tissue is identified as a light green
group of pixels on the VH IVUS screen. This tissue is
characterised by loosely packed collagen fibres with lipid
accumulation. There is no necrotic tissue and no or few
cholesterol clefts. Large areas of fibrofatty tissue retain matrix.
Necrotic core tissue is identified as a red group of pixels on the
VH IVUS screen. This tissue is characterised by a high level of
lipid with many necrotic cells and remnants of dead lympho-
cytes and foam cells. There are few or no collagen fibres, the
cellular structure (matrix) is not well organised and there is
poor mechanical stability. Microcalcification is often present as
a byproduct of dead cells, or as a result of intraplaque
haemorrhage.
Dense calcium is identified as a white pixel group on the VH
IVUS screen. This tissue is characterised by compact calcium
crystals.
CLINICAL ROLE OF THE TECHNOLOGY
In recent studies, high-risk lesions and multiple plaque
ruptures in acute patients were detected by IVUS,15 16 even
though IVUS imaging is limited regarding analysis of the exact
plaque composition. Calcified and dense fibrotic tissues may
have lateral shadowing and are therefore not easy to
differentiate. The differential diagnoses of areas with low echo
reflections includes lipid-rich or fibrotic tissue, intraplaque
haemorrhage or even thrombus and lumen area. A more
detailed diagnosis of the plaque composition is enabled by VH
IVUS.
In vivo studies using VH IVUS have shown that vulnerable
plaques (thin cap fibroatheromas, TCFAs) occur more often in
patients with acute coronary syndrome (ACS) than in patients
with stable angina.17 Angiographic studies detected that acute
coronary occlusions leading to ST segment elevation myocardial
infarction tend to cluster in predictable hot spots, especially in
the proximal third of the coronary arteries.18 VH IVUS analysis
confirmed these findings. Depending on the distance from the
coronary ostium, the proximal segments showed significantly
higher levels of necrotic core, but no change in the resting
plaque components.19
Positive remodelling processes increasing plaque proliferation
were shown20 and confirmed by IVUS.21 VH IVUS analysis
confirmed the relationship of outward and inward remodelling
processes to plaque composition. In a small study, the in vivo
plaque composition and morphology assessed using IVUS-RF
analysis was related to coronary remodelling, supporting the
role of plaque composition in the mechanisms of vessel
remodelling. Positive remodelling is associated with high-risk
lesions such as fibroatheromas or TCFA, whereas negative
remodelling is associated with less vulnerable lesions such as
intimal thickening or fibrous plaque composition.22
Figure 1 The radiofrequency signal
received by the intravascular ultrasound
(IVUS) catheter is divided into frequency
‘‘windows’’. The signal profile from each of
those windows is processed through
sophisticated algorithms. The signal profile is
then matched to a known database of signal
profiles previously mapped to one of the four
main tissue types found in coronary plaques
by histology. The decision tree assigns the
corresponding colour to the orientation-
matched pixel on the image. Finally, the
virtual histology (VH) image is reconstructed.
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In terms of secondary prevention, it is clinically important to
detect progression of coronary artery disease and, moreover, to
predict coronary lesions with significant progression up to ACS.
Angiographic studies showed clinically relevant progression in
non-culprit lesions with a non-target lesion percutaneous
coronary intervention during 1 year follow-up, significantly
depending on the degree of coronary artery disease.23 Earlier
angiographic studies showed different types of stenosis
progression in terms of mild and rapid progression.24 Complex
lesion morphology and unstable presentation were important
factors for rapid stenosis progression.25 However, coronary
angiography and clinical parameters were poor surrogates to
predict future events in a broad cohort of patients who had
percutaneous coronary intervention. In addition, non-invasive
imaging failed to identify coronary plaques with potential
rupture and consecutive ACS. This highlights the need for
further study to identify potentially vulnerable lesions.
Catheter-based invasive diagnosis with VH IVUS can
distinguish between different plaque types. It is able to detect
criteria of plaque vulnerability. Criteria for increased vulner-
ability based on histopathological studies are, at present, the
extent of confluent necrotic core, evidence of fibrotic cap,
pattern of calcification, positive coronary remodelling, degree of
luminal stenosis and localisation of the interrogated lesion.
However, there is currently no evidence to favour invasive
treatment of a vulnerable plaque. A recent meta-analysis found
the re-stenosis risk after revascularisation in angiographic
intermediate lesions corresponded with the re-stenosis risk in
clinically relevant stenoses and was therefore unacceptably high.26
We need prospective randomised studies to evaluate prophy-
lactic treatment with coronary stent implantation in compar-
ison with medical treatment. The PROSPECT (Providing
Regional Observations to Study Predictors of Events in the
Coronary Tree) trial is a natural history study to analyse the
relationship of unexpected acute coronary syndrome and
progression of coronary artery disease. This is the first
prospective study to detect lesions that are considered prone
to rupture with intravascular imaging.
Figure 2 Automatic characterisation of the
atherosclerotic plaque by virtual histology.
After comparison of the raw frequency data-
derived spectrum curves with the spectrum
parameter of the database, the four colour-
coded plaque components produced are
presented. (A) Intravascular ultrasound-
greyscale image showing large excentric
plaque morphology. (B) The corresponding
colour-coded virtual histology image depicts
the specific plaque components.
Figure 3 Plaque classification by
intravascular ultrasound–virtual histology
distinguishes between intimal thickening
(A, B), and more vulnerable lesions, such as
fibroatheroma (C, D, E). In thin cap
fibroatheroma (TCFA) (D), the necrotic core
is lying on the surface of the plaque.
Compared with the fibroatheroma (C) the
fibrous cap is not visible. TCFA with multiple
layers of necrotic areas (E) suggests multiple
previous ruptures. (A) Adaptive intimal
thickening; (B) pathological intimal
thickening; (C) fibroatheroma; (D) IVUS-
defined TCFA; (E) TCFA, multiple layer;
(F) fibrocalcific plaque.
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The longitudinal analysis of a target lesion detects the extent
of the necrotic core and the vulnerable plaque. As a
consequence, treatment of the lesion should cover this plaque
and potentially avoid future ruptures instead of covering just
the minimum lumen site.
In vivo plaque classification by VH IVUS is based on
histopathological studies.27 Coronary lesions are differentiated
in plaques with adaptive and pathological intimal thickening,
fibroatheromas and fibrotic calcified plaques. For risk stratifi-
cation, it is important to differentiate between the afore-
mentioned plaque types, and especially to distinguish between
adaptive intimal thickening and fibrous cap atheroma (fig 3).
‘‘Niche’’ interventional applications of greyscale IVUS are the
characterisation and quantitative analysis of left main coronary
artery disease, transplant vasculopathy and planning of
debulking strategies. The additional information about the
exact plaque composition by VH IVUS in these clinical settings
may further optimise stratification of these patients.
As IVUS is best able to assess stent underexpansion and
malapposition, IVUS guidance may play an increasing role in
the drug-eluting stent era. In addition to IVUS-guided
quantitative stent optimisation, determination of the plaque
composition and distribution by VH IVUS may be helpful for
choosing stent types and dimensions and therefore may further
improve the clinical outcome.
CURRENT LIMITATIONS OF THE TECHNIQUE
A current limitation is the automatic border detection, which
necessitates correction of the planimetry. Accurate borders are
critically important, as the VH software characterises the entire
plaque area with the four tissue types. Accurate border
correction affords experience in greyscale IVUS imaging and
analysis. Longer segments of plaque can be analysed, but this is
time consuming and therefore not practical in the catheterisa-
tion laboratory. Whole segment analysis is available for off-line
assessment.
The axial resolution (100–200 mm) is too low to detect critical
fibrous cap thickness, which is currently defined as 65 mm;
however the threshold for critical cap thickness is under
consideration and is probably higher. The introduction of the
next generation high-frequency IVUS catheter enables better
axial resolution.
Despite better differentiation of low echogenic reflexes with
VH IVUS, differential diagnosis between soft plaque material
and thrombus is currently not possible by RF analysis.
Thrombus detection could help localise the extent and also
origin of the plaque rupture in patients with ACS. The
probability of detecting the tissue components in the plaque
area correctly is very high. In our opinion, this accuracy is
weakened in areas of lateral shadowing due to calcified or
dense fibrotic tissue. This may influence the exact measure-
ment of the amount and extent of necrotic core. As the area
crucial for vulnerability is near the surface of the plaque, this
limitation does not directly account for the underestimation of
vulnerable lesions.
The VH IVUS analysis represents, in terms of an analysed
TCFA, the current vulnerability of the interrogated lesion at
that stage. The duration of this vulnerable stage and the exact
time interval of progression or regression of coronary artery
disease are unknown. Thrombus, as the primary surrogate for
acute coronary thrombosis cannot be detected to date and
therefore has to be excluded from the VH IVUS analysis.
Keeping in mind that the vulnerability of high-risk lesions
may be only temporary, with changing plaque structures in
short time intervals, prospective serial VH IVUS studies should
be performed in vivo to clarify the natural history of these
vulnerable lesions.
FUTURE DEVELOPMENT
VH IVUS is the most promising technique to detect vulnerable
plaques and therefore to assess their natural history.
Prospective trials using serial VH IVUS analysis may help to
distinguish plaques prone to rupture and, as a consequence, to
lead to cardiac events.
The treatment of these vulnerable lesions and coronary artery
disease might be changed according to the results of these
prospective studies. Regarding the technical development, the
next high-frequency IVUS catheter (Revolution, 45 MHz,
Volcano Corporation) is a rotational IVUS imaging catheter
enabling increased spatial resolution in grayscale IVUS and
accordingly VH IVUS. The phased-array and rotational cathe-
ters can be used on the same platform.
A cross-sectional area analysis and also length analysis will
provide a vessel profile imaging in addition to the tomographic
Figure 4 Volcano s5/i provides on-line
real-time intravascular ultrasound–virtual
histology in both tomographic and
longitudinal views during image acquisition.
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view. Quantitative and qualitative lesion length analyses are
provided to view the extent and distribution of the necrotic
area. The incorporation of IVUS in the catheterisation
laboratory will be optimised. The Volcano s5/i IVUS imaging
system allows for customised incorporation of IVUS into the
interventional catheterisation laboratory. In addition, Volcano
s5/i provides true real-time VH IVUS overlaid onto the greyscale
cross section and onto the longitudinal view during image
acquisition (fig 4). AIM (Angio IVUS Mapping) is a future
option with synchronised coregistration of VH IVUS and
coronary angiography (collaboration with Paieon Medical,
Rosh Haaiyn, Israel) providing a mapping of IVUS images to
two- or three-dimensional quantitative coronary angiography.
CONCLUSION
Coronary angiography and clinical parameters are poor
surrogates to predict future events in patients with coronary
artery disease. This highlights the need for further studies to
identify potentially vulnerable lesions. VH IVUS is currently the
best catheter-based imaging tool to detect most of the criteria of
plaque vulnerability based on pathology. Detection of high-risk
lesions may have an influence on the treatment and prevention
of acute coronary syndrome (fig 5). In clinical practice, several
issues can be addressed by VH IVUS. On the basis of
classification of pathological lesions, fibroatheroma can be
distinguished from lesions with intimal thickening, and
vulnerability criteria allow further risk stratification of fibrous
cap atheroma. Currently, we have no evidence to support
treatment of vulnerable lesions as a preventive strategy because
there is uncertainty regarding the re-stenosis risk compared
with the spontaneous rupture rate of high-risk lesions. Our
knowledge about the natural history of atherosclerosis includ-
ing lesion classification is mainly based on histopathological
studies. As VH IVUS enables in vivo diagnostic of athero-
sclerotic histopathology, we can complete our understanding of
the genesis and progression of this disease, avoiding selective
patient cohorts.
Using VH-derived lesion analysis, coronary interventions may
be modified using lesion-specific strategies. With the knowl-
edge of the longitudinal distribution of vulnerable lesions, the
culprit lesion is easier to identify and better treated by complete
stent coverage.
The additional value of VH IVUS in specially indicated IVUS-
guided coronary interventions (niche IVUS application) needs
to be determined.
Authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Andreas Ko¨nig, Volker Klauss, Department of Medicine, Division of
Cardiology, Medizinische Poliklinik – Innenstadt, Munich, Germany
Competing interests: None declared.
Figure 5 Patient with an acute coronary syndrome and occluded left anterior descending artery. Greyscale intravascular ultrasound shows severe
atherosclerosis in the entire vessel and plaque rupture in the medial segment. The corresponding VH images show a high level of necrotic core and several
layers of necrotic core with microcalcification, suggesting previous plaque ruptures.
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